MedTrace Logo

PRospective Evaluation of Peripartum Anticoagulation ManaGement for ThrOmboembolism

NCT05756244 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 825

Last updated 2025-11-28

No results posted yet for this study

Summary

The PREP and GO study is an international multicentre prospective cohort evaluating anticoagulation management strategies around labor and delivery and the postpartum period.

Conditions

  • Pregnancy Related
  • Venous Thromboembolism

Sponsors & Collaborators

  • University of Calgary

    lead OTHER

Principal Investigators

  • Leslie Skeith, MD · University of Calgary

  • Isabelle Malhamé, MD · McGill University

  • Kinga Malinowski, MD · University of Toronto

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-04-04
Primary Completion
2029-06-30
Completion
2029-12-31

Countries

  • United States
  • Canada
  • Denmark
  • France
  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05756244 on ClinicalTrials.gov